Search Results - "Urinary bladder neoplasms/mortality"

Perioperative Complications and In-Hospital Mortality in Paraplegic Radical Cystectomy Patients

Authors: Di Bello, Francesco Siech, Carolin de Angelis, Mario et al.

Source: Ann Surg Oncol

Subject Terms: Male, Paraplegia, Bladder, ICU, Morbidity, NIS, Surgery, Urinary Bladder Neoplasms/complications [MeSH], Aged [MeSH], Postoperative Complications/mortality [MeSH], Risk Factors [MeSH], Hospital Mortality [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Male [MeSH], Intraoperative Complications/mortality [MeSH], Postoperative Complications/etiology [MeSH], Paraplegia/mortality [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Cystectomy/adverse effects [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Paraplegia/etiology [MeSH], Survival Rate [MeSH], Urologic Oncology, Prognosis [MeSH], Cystectomy/mortality [MeSH], Middle Aged, Cystectomy, Prognosis, Survival Rate, Postoperative Complications, Urinary Bladder Neoplasms, Risk Factors, Humans, Female, Hospital Mortality, Intraoperative Complications, Aged, Follow-Up Studies, Retrospective Studies

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39377845
https://hdl.handle.net/11588/982706
https://hdl.handle.net/11380/1366929
https://doi.org/10.1245/s10434-024-16332-3
https://repository.publisso.de/resource/frl:6522422

Bladder cancer incidence and mortality among men with and without castration therapy for prostate cancer – a nation-wide cohort study

Authors: Josephine M. Hyldgaard Mette Nørgaard Peter E. Hjort et al.

Source: Acta Oncol
Acta Oncologica, Vol 63, Iss 1 (2024)
Hyldgaard, J M, Nørgaard, M, Hjort, P B & Jensen, J B 2024, 'Bladder cancer incidence and mortality among men with and without castration therapy for prostate cancer-a nation-wide cohort study', Acta Oncologica, vol. 63, pp. 746-754. https://doi.org/10.2340/1651-226X.2024.40969

Subject Terms: Male, Denmark, Urinary Bladder Cancer, Cohort Studies, androgen receptor, gender, Humans, Registries, Prostatic Neoplasms/mortality, RC254-282, Aged, Aged, 80 and over, Incidence, Registries/statistics & numerical data, antihormonal treatment, Gender, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Prostatic Neoplasms, Androgen Antagonists, Middle Aged, Denmark/epidemiology, Androgen receptor, Urinary Bladder Neoplasms, Urinary Bladder Neoplasms/mortality, Anti-hormonal Treatment, Urinary bladder cancer, Original Article, Androgen Antagonists/therapeutic use, Orchiectomy

Access URL: https://pubmed.ncbi.nlm.nih.gov/39319939
https://doaj.org/article/767b8693327142519139d8b9b2f63da2

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Authors: Blanc, Jérémy Carnot, Aurélien Barthélémy, Philippe et al.

Source: Journal for ImmunoTherapy of Cancer, 13 (5), e012045 (2025-05-24)

Subject Terms: Bladder Cancer, Genitourinary Cancer, Immune Checkpoint Inhibitor, Neoadjuvant, Antibodies, Monoclonal, Humanized, avelumab, Cisplatin, Gemcitabine, Deoxycytidine, Humans, Male, Female, Aged, Middle Aged, Cisplatin/administration & dosage, Aged, 80 and over, Neoplasm Invasiveness, Deoxycytidine/analogs & derivatives, Deoxycytidine/administration & dosage, Urinary Bladder Neoplasms/drug therapy, Urinary Bladder Neoplasms/pathology, Urinary Bladder Neoplasms/mortality, Neoadjuvant Therapy/methods, Antibodies, Monoclonal, Humanized/therapeutic use, Antibodies, Monoclonal, Humanized/pharmacology, Antibodies, Monoclonal, Humanized/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols, Neoadjuvant Therapy, Urinary Bladder Neoplasms, Immunology and Allergy, Immunology, Molecular Medicine, Oncology, Pharmacology, Cancer Research, Human health sciences, Sciences de la santé humaine, Oncologie

Relation: https://syndication.highwire.org/content/doi/10.1136/jitc-2025-012045; urn:issn:2051-1426

Access URL: https://orbi.uliege.be/handle/2268/333581

Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer

Authors: Pichler, Renate Fritz, Josef Maier, Sarah et al.

Source: Cancer Immunol Immunother
Cancer Immunology, Immunotherapy, Vol 74, Iss 1, Pp 1-10 (2024)

Subject Terms: Male, Urologic Neoplasms, Target trial emulation, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, 03 medical and health sciences, 0302 clinical medicine, Urothelial cancer, Humans, Immortal time bias, Aged, 80 and over [MeSH], Aged [MeSH], Urinary Bladder Neoplasms/drug therapy [MeSH], Metastatic, Drug-Related Side Effects and Adverse Reactions/etiology [MeSH], Adverse events, Male [MeSH], Immune Checkpoint Inhibitors/adverse effects [MeSH], Urologic Neoplasms/mortality [MeSH], Carcinoma, Transitional Cell/drug therapy [MeSH], Carcinoma, Transitional Cell/mortality [MeSH], Female [MeSH], Carcinoma, Transitional Cell/immunology [MeSH], Urologic Neoplasms/drug therapy [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/immunology [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Urologic Neoplasms/immunology [MeSH], Research, Immunotherapy, Urologic Neoplasms/pathology [MeSH], Neoplasm Metastasis, Immune Checkpoint Inhibitors, RC254-282, Aged, Retrospective Studies, Aged, 80 and over, Carcinoma, Transitional Cell, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Urinary Bladder Neoplasms, Female

Access URL: https://pubmed.ncbi.nlm.nih.gov/39708183
https://doaj.org/article/dabe3b175be24efc9e75632af91127fd
https://repository.publisso.de/resource/frl:6522160

Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortality

Authors: Gregor Duwe Isabel Wagner Katarzyna E. Banasiewicz et al.

Contributors: Gregor Duwe Isabel Wagner Katarzyna E. Banasiewicz et al.

Source: World J Urol

Subject Terms: Male, Aged, 80 and over, Research, 610 Medizin, Age Factors, Cystectomy, Risk Assessment, Postoperative Complications, Urinary Bladder Neoplasms, Predictive Value of Tests, 610 Medical sciences, Preoperative Period, Humans, Female, Female [MeSH], Age Factors [MeSH], Postoperative complications, Aged, 80 and over [MeSH], Morbidity, Comorbidities, Aged [MeSH], Geriatric assessment, Postoperative Complications/mortality [MeSH], Humans [MeSH], Postoperative Complications/epidemiology [MeSH], Predictive Value of Tests [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Geriatric Assessment/methods [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Cystectomy/methods [MeSH], Mortality, Male [MeSH], Preoperative Period [MeSH], Outcome improvement, Risk Assessment/methods [MeSH], Radical cystectomy, Geriatric Assessment, Aged, Retrospective Studies

Access URL: https://pubmed.ncbi.nlm.nih.gov/39347804
https://repository.publisso.de/resource/frl:6524624

Return to work improves quality of life and reduces psychosocial distress after radical cystectomy: data from a contemporary series of 230 German patients

Authors: Bahlburg, Henning Reike, Moritz Tully, Karl et al.

Source: J Cancer Surviv

Subject Terms: Male, Middle Aged, Cystectomy, Psychological Distress, Article, 3. Good health, Bladder cancer, Surveys and Questionnaires [MeSH], Female [MeSH], Aged [MeSH], Psychological Distress [MeSH], Return to Work/statistics, Humans [MeSH], Stress, Psychological/epidemiology [MeSH], Prospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Cystectomy [MeSH], Germany/epidemiology [MeSH], Urinary Bladder Neoplasms/psychology [MeSH], Urinary Bladder Neoplasms/surgery [MeSH], Return to work, Quality of life, Male [MeSH], Quality of Life [MeSH], Return to Work/psychology [MeSH], Psychosocial distress, Radical cystectomy, Return to Work, Urinary Bladder Neoplasms, Germany, Surveys and Questionnaires, Quality of Life, Humans, Female, Prospective Studies, Stress, Psychological, Aged

Access URL: https://pubmed.ncbi.nlm.nih.gov/37145330
https://repository.publisso.de/resource/frl:6493770

The HELENA study: Hexvix®-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy—a prospective randomized controlled open-label multicenter non-inferiority study

Authors: Gierth, Michael Breyer, Johannes Zeman, Florian et al.

Source: World J Urol

Subject Terms: Adult, Male, Mitomycin, Bladder cancer, Urothelial carcinoma, Aged, 80 and over [MeSH], Aged [MeSH], Antineoplastic Agents/administration, Aminolevulinic Acid/analogs, Intravesical chemotherapy, Cystectomy [MeSH], Original Article, Male [MeSH], Carcinoma/therapy [MeSH], Carcinoma/mortality [MeSH], Female [MeSH], Cystoscopy [MeSH], Adult [MeSH], Humans [MeSH], Mitomycin/administration, Prospective Studies [MeSH], Administration, Intravesical [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Aminolevulinic Acid/administration, Transurethral resection, Urinary Bladder Neoplasms/therapy [MeSH], Carcinoma/pathology [MeSH], Chemotherapy, Adjuvant [MeSH], Photosensitizing Agents/administration, Disease-Free Survival [MeSH], Photochemotherapy [MeSH], 610 Medizin, Antineoplastic Agents, Cystectomy, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Humans, Prospective Studies, Aged, Aged, 80 and over, 2. Zero hunger, ddc:610, Photosensitizing Agents, Carcinoma, Aminolevulinic Acid, Cystoscopy, Middle Aged, 3. Good health, Administration, Intravesical, Photochemotherapy, Urinary Bladder Neoplasms, Chemotherapy, Adjuvant, Female, Urothelial carcinoma, Bladder cancer, Intravesical chemotherapy, Transurethral resection

File Description: application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03719-0.pdf
https://pubmed.ncbi.nlm.nih.gov/34002265
https://www.ncbi.nlm.nih.gov/pubmed/34002265
https://pubmed.ncbi.nlm.nih.gov/34002265/
https://link.springer.com/content/pdf/10.1007/s00345-021-03719-0.pdf
https://link.springer.com/article/10.1007/s00345-021-03719-0
https://epub.uni-regensburg.de/45814/
https://europepmc.org/article/MED/34002265
https://repository.publisso.de/resource/frl:6447729
https://epub.uni-regensburg.de/45814/

Renal and Bladder Cancer During Pregnancy: A Review of 47 Cases and Literature-based Recommendations for Management: A Review of 47 Cases and Literature-based Recommendations for Management

Authors: Maggen, Charlotte Linssen, Jasmijn Mhallem Gziri, Mina et al.

Contributors: Maggen, Charlotte Linssen, Jasmijn Mhallem Gziri, Mina et al.

Source: Maggen, C, Linssen, J, Gziri, M M, Zola, P, Cardonick, E, de Groot, C J M, Garcia, A C, Fruscio, R, Drochytek, V, Van Calsteren, K, Albersen, M, Amant, F & for the International Network on Cancer, Infertility and Pregnancy (INCIP). 2021, 'Renal and Bladder Cancer During Pregnancy : A Review of 47 Cases and Literature-based Recommendations for Management', Urology, vol. 151, pp. 118-128. https://doi.org/10.1016/j.urology.2020.08.084
Urology, Vol. 151, p. 118-128 (2021)

Subject Terms: Renal cancer, bladder cancer, pregnancy, Adult, Pain, Pain/etiology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, TUMOR, Pregnancy, Humans, Labor, Induced, Registries, Kidney Neoplasms/mortality, Hematuria, Retrospective Studies, Science & Technology, WOMAN, Pregnancy Complications, Neoplastic/mortality, 2ND TRIMESTER, 3202 Clinical sciences, Infant, Newborn, 1103 Clinical Sciences, Urology & Nephrology, CELL CARCINOMA, RADICAL NEPHRECTOMY, Middle Aged, International Network on Cancer, Infertility and Pregnancy (INCIP), CARCINOMA COMPLICATING PREGNANCY, Kidney Neoplasms, 3. Good health, Hematuria/etiology, Urinary Bladder Neoplasms, Urinary Bladder Neoplasms/mortality, young adult, Premature Birth, Female, Life Sciences & Biomedicine, Pregnancy Complications, Neoplastic

Access URL: https://lirias.kuleuven.be/bitstream/20.500.12942/690427/2/Urological%20cancers%20pregnancy.pdf
https://pubmed.ncbi.nlm.nih.gov/33203520
https://www.narcis.nl/publication/RecordID/oai%3Apure.atira.dk%3Apublications%2Fd0cc31e1-f4fb-4feb-afe2-fd5d4cf33b2b
https://www.sciencedirect.com/science/article/pii/S0090429520312711
https://research.vumc.nl/en/publications/renal-and-bladder-cancer-during-pregnancy-a-review-of-47-cases-an
https://pubmed.ncbi.nlm.nih.gov/33203520/
https://www.ncbi.nlm.nih.gov/pubmed/33203520
https://europepmc.org/article/MED/33203520
https://research.vumc.nl/en/publications/d0cc31e1-f4fb-4feb-afe2-fd5d4cf33b2b
https://hdl.handle.net/2078.1/268367
https://biblio.vub.ac.be/vubir/(75fada73-a660-4c4d-9dc6-b5c15cb80c59).html

Utility of pT3 substaging in lymph node-negative urothelial carcinoma of the bladder: do pathologic parameters add to prognostic sub-stratification?

Authors: Maas, Moritz Mischinger, Johannes Compérat, Eva et al.

Source: World J Urol

Subject Terms: Adult, Aged, 80 and over, Male, ddc:610, Carcinoma, Transitional Cell, Middle Aged, Topic Paper, Prognosis, Tumor Burden, 3. Good health, Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, Aged, 80 and over [MeSH], Aged [MeSH], Tumor invasion front, Urinary Bladder Neoplasms/classification [MeSH], Carcinoma, Transitional Cell/pathology [MeSH], Neoplasm Staging [MeSH], Male [MeSH], Lymph Nodes [MeSH], Tumor Burden [MeSH], Carcinoma, Transitional Cell/mortality [MeSH], Muscle-invasive bladder cancer, Carcinoma, Transitional Cell/classification [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Survival Rate [MeSH], Prognosis [MeSH], Perivesical extension, Pathological staging, Patient outcome, Humans, Female, Lymph Nodes, 10. No inequality, Aged, Neoplasm Staging, Retrospective Studies

File Description: application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007/s00345-021-03697-3.pdf
https://pubmed.ncbi.nlm.nih.gov/33881556
https://link.springer.com/content/pdf/10.1007/s00345-021-03697-3.pdf
https://link.springer.com/article/10.1007/s00345-021-03697-3
https://europepmc.org/article/MED/33881556
https://pubmed.ncbi.nlm.nih.gov/33881556/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571207
https://www.ncbi.nlm.nih.gov/pubmed/33881556
https://repository.publisso.de/resource/frl:6447723
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-266535
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/26653
https://opus.bibliothek.uni-wuerzburg.de/files/26653/Maas_World_Journal.pdf
https://doi.org/10.1007/s00345-021-03697-3

Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer

Authors: Stefan Garczyk Felix Bischoff Ursula Schneider et al.

Source: Virchows Arch
Virchows Archiv 479(2), 325-332 (2021). doi:10.1007/s00428-021-03054-0

Subject Terms: Adult, Male, Bladder cancer, Molecular subtypes, Age Factors [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Risk Assessment [MeSH], Progression-Free Survival [MeSH], Risk Factors [MeSH], Tissue Array Analysis [MeSH], Intratumoral heterogeneity, Urothelium/chemistry [MeSH], Original Article, Urinary Bladder Neoplasms/chemistry [MeSH], Male [MeSH], Neoplasm Recurrence, Local [MeSH], Biomarkers, Tumor/analysis [MeSH], NMIBC, Female [MeSH], Carcinoma in Situ/chemistry [MeSH], Carcinoma in Situ/mortality [MeSH], Adult [MeSH], Humans [MeSH], Predictive Value of Tests [MeSH], Retrospective Studies [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Neoplasm Invasiveness [MeSH], Smoking/adverse effects [MeSH], Urinary Bladder Neoplasms/therapy [MeSH], Immunohistochemistry [MeSH], Carcinoma in Situ/pathology [MeSH], Urothelium/pathology [MeSH], CIS, Carcinoma in Situ/therapy [MeSH], Carcinoma in situ, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Risk Factors, Biomarkers, Tumor, Humans, Neoplasm Invasiveness, 10. No inequality, Aged, Retrospective Studies, Aged, 80 and over, Smoking, Age Factors, Middle Aged, Immunohistochemistry, Progression-Free Survival, 3. Good health, Tissue Array Analysis, Female, Neoplasm Recurrence, Local, Carcinoma in Situ

Access URL: https://link.springer.com/content/pdf/10.1007/s00428-021-03054-0.pdf
https://pubmed.ncbi.nlm.nih.gov/33650041
https://pubmed.ncbi.nlm.nih.gov/33650041/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364543
https://link.springer.com/article/10.1007/s00428-021-03054-0
https://www.ncbi.nlm.nih.gov/pubmed/33650041
https://link.springer.com/content/pdf/10.1007/s00428-021-03054-0.pdf
https://repository.publisso.de/resource/frl:6450052
https://publications.rwth-aachen.de/record/846209

Bladder cancer stage and mortality: urban vs. rural residency

Authors: Claudia Collà Ruvolo Pierre I. Karakiewicz Luis A. Kluth et al.

Source: Cancer Causes Control

Subject Terms: Social differences, Aged, 80 and over, Male, Rural Population, ddc:610, Original Paper, Urban Population, Bladder cancer, 1. No poverty, Geographical disparities, Middle Aged, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Urinary Bladder Neoplasms, 11. Sustainability, Female [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Humans [MeSH], Urinary Bladder Neoplasms/mortality [MeSH], Middle Aged [MeSH], Urban Population [MeSH], Urinary Bladder Neoplasms/pathology [MeSH], Rural Population [MeSH], Neoplasm Staging [MeSH], Male [MeSH], Stage at presentation, Treatment rates, Humans, Female, Aged, Neoplasm Staging

File Description: application/pdf

Access URL: https://link.springer.com/content/pdf/10.1007/s10552-020-01366-1.pdf
https://pubmed.ncbi.nlm.nih.gov/33230694
https://hdl.handle.net/11588/989055
https://link.springer.com/article/10.1007/s10552-020-01366-1
https://www.ncbi.nlm.nih.gov/pubmed/33230694
https://pubmed.ncbi.nlm.nih.gov/33230694/
https://link.springer.com/content/pdf/10.1007/s10552-020-01366-1.pdf
https://europepmc.org/article/MED/33230694
https://repository.publisso.de/resource/frl:6470738
https://hdl.handle.net/11588/989055
https://doi.org/10.1007/s10552-020-01366-1

Oncological outcome according to attainment of pentafecta after robot‐assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database

Authors: Sangchul Lee Jong Kil Nam Koon Ho Rha et al.

Contributors: Sangchul Lee Jong Kil Nam Koon Ho Rha et al.

Source: BJU International. 127:182-189

Subject Terms: Robotic Surgical Procedures / methods, Male, uroonc, Databases, Factual, Urinary Bladder Neoplasms / surgery, Operative Time, Urinary Bladder, Urinary Bladder / surgery, Cystectomy, survival, Cystectomy / methods, Disease-Free Survival, blcsm, Databases, Neoplasm Staging / methods, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Robotic Surgical Procedures, Risk Factors, Republic of Korea, Postoperative Complications / epidemiology, Humans, Factual, Republic of Korea / epidemiology, Neoplasm Staging, Retrospective Studies, Urinary Bladder / diagnostic imaging, Incidence, Middle Aged, Prognosis, Bladder Cancer, robot cystectomy, 3. Good health, Survival Rate, Survival Rate / trends, Urinary Bladder Neoplasms, Urinary Bladder Neoplasms / mortality, Urinary Bladder Neoplasms / diagnosis, Female, Follow-Up Studies

Access URL: https://pubmed.ncbi.nlm.nih.gov/32682331
https://bjui-journals.onlinelibrary.wiley.com/doi/epdf/10.1111/bju.15178
https://www.ncbi.nlm.nih.gov/pubmed/32682331
https://pubmed.ncbi.nlm.nih.gov/32682331/

Sex Differences in Urothelial Bladder Cancer Survival

Authors: Radkiewicz, Cecilia Edgren, Gustaf Johansson, Anna Louise Viktoria et al.

Source: Clinical Genitourinary Cancer. 18(1):26-34

Subject Terms: Registries, Sex factors, Survival analysis, Sweden/epidemiology, Urinary bladder neoplasms/mortality

File Description: print

Access URL: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-168991

Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC

Authors: Franco Gaboardi Jihad H. Kaouk Andrew A. Wagner et al.

Contributors: Franco Gaboardi Jihad H. Kaouk Andrew A. Wagner et al.

Source: Journal of Urology. 203:57-61

Subject Terms: Male, Reoperation, Urinary Bladder Neoplasms / pathology, Urinary Bladder Neoplasms / surgery, Operative Time, Neoadjuvant Therapy, Reoperation / statistics & numerical data, morbidity, Antineoplastic Agents, Cystectomy, Patient Readmission, 03 medical and health sciences, cystectomy, Postoperative Complications, 0302 clinical medicine, Adjuvant, Robotic Surgical Procedures, robotic surgical procedures, Chemotherapy, Humans, Aged, Retrospective Studies, Urinary Bladder Neoplasms / drug therapy, Antineoplastic Agents / therapeutic use, mortality, 3. Good health, Survival Rate, Urinary Bladder Neoplasms, Chemotherapy, Adjuvant, Urinary Bladder Neoplasms / mortality, Patient Readmission / statistics & numerical data, urinary bladder

Access URL: https://pubmed.ncbi.nlm.nih.gov/31600114
https://ir.ymlib.yonsei.ac.kr/handle/22282913/178988
https://www.auajournals.org/doi/10.1097/JU.0000000000000445
https://pubmed.ncbi.nlm.nih.gov/31600114/
https://yonsei.pure.elsevier.com/en/publications/neoadjuvant-chemotherapy-is-not-associated-with-adverse-periopera
https://www.ncbi.nlm.nih.gov/pubmed/31600114
https://scholarlycommons.henryford.com/urology_articles/334/

Lymphadenectomy for bladder cancer: indications and controversies.

Authors: Burkhard, F.C. Roth, B. Zehnder, P. et al.

Subject Terms: Biopsy, Needle, Carcinoma, Transitional Cell/mortality, Transitional Cell/pathology, Transitional Cell/surgery, Cystectomy/methods, Cystectomy/mortality, Humans, Immunohistochemistry, Lymph Node Excision/standards, Lymph Node Excision/trends, Lymph Nodes/pathology, Lymph Nodes/surgery, Male, Neoplasm Invasiveness, Neoplasm Recurrence, Local/mortality, Local/pathology, Local/surgery, Neoplasm Staging, Pelvis/pathology, Pelvis/surgery, Prognosis, Risk Assessment, Survival Analysis, Urinary Bladder Neoplasms/mortality, Urinary Bladder Neoplasms/pathology, Urinary Bladder Neoplasms/surgery

Relation: Urologic Clinics of North America; https://iris.unil.ch/handle/iris/35159; serval:BIB_2C9416C4767A; 000297824700004

Availability: https://iris.unil.ch/handle/iris/35159
https://doi.org/10.1016/j.ucl.2011.07.011

Declining mortality from bladder cancer in Europe

Authors: Ferlay, Jacques Randi, Giorgia Bosetti, Cristina et al.

Subject Terms: Adult, Age Distribution, Europe/epidemiology, Female, Humans, Male, Middle Aged, Mortality/trends, Occupational Exposure/adverse effects, Regression Analysis, Smoking/adverse effects, Smoking/mortality, Smoking/trends, Urinary Bladder Neoplasms/etiology, Urinary Bladder Neoplasms/mortality

Relation: BJU International; https://iris.unil.ch/handle/iris/214898; serval:BIB_9BF23026A42F; 000251503000005

Availability: https://iris.unil.ch/handle/iris/214898
https://doi.org/10.1111/j.1464-410X.2007.07239.x

Positive Pre-cystectomy Biopsies of the Prostatic Urethra or Bladder Neck Do Not Necessarily Preclude Orthotopic Bladder Substitution.

Authors: Roth, B. Furrer, M.A. Giannakis, I. et al.

Subject Terms: Biopsy/statistics & numerical data, Cystectomy/methods, Female, Follow-Up Studies, Humans, Male, Neoplasm Recurrence, Local/epidemiology, Local/pathology, Local/prevention & control, Patient Selection, Prostate/pathology, Retrospective Studies, Survival Analysis, Treatment Outcome, Urethra/pathology, Urethral Neoplasms/epidemiology, Urethral Neoplasms/pathology, Urethral Neoplasms/prevention & control, Urinary Bladder/pathology, Urinary Bladder/surgery, Urinary Bladder Neoplasms/mortality, Urinary Bladder Neoplasms/pathology, Urinary Bladder Neoplasms/surgery, Urinary Reservoirs, Continent, biopsy, cystectomy, prostate, urethra

Relation: The Journal of urology; https://iris.unil.ch/handle/iris/168333; serval:BIB_73D2B9177497; 000475849900072

Availability: https://iris.unil.ch/handle/iris/168333
https://doi.org/10.1097/JU.0000000000000034

Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis

Authors: Bosetti, Cristina Bertuccio, Paola Levi, Fabio et al.

Subject Terms: Breast Neoplasms/mortality, Colorectal Neoplasms/mortality, European Union/statistics & numerical data, Female, Head and Neck Neoplasms/mortality, Humans, Male, Mortality/trends, Neoplasms/mortality, Prostatic Neoplasms/mortality, Regression Analysis, Sex Distribution, Sex Factors, Stomach Neoplasms/mortality, Survival Rate, Tobacco Use Cessation/statistics & numerical data, Urinary Bladder Neoplasms/mortality, Uterine Neoplasms/mortality

File Description: application/pdf

Relation: Annals of Oncology; https://iris.unil.ch/handle/iris/149689; serval:BIB_6C44865B656B; 000254470400005

Availability: https://iris.unil.ch/handle/iris/149689
https://doi.org/10.1093/annonc/mdm597

Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.

Authors: Kurth, K. Tunn, U. Ay, R. et al.

Subject Terms: Aged, 80 and over, Antineoplastic Agents, Alkylating/therapeutic use, Carcinoma, Transitional Cell/drug therapy, Transitional Cell/mortality, Transitional Cell/surgery, Chemotherapy, Adjuvant, Disease Progression, Doxorubicin/therapeutic use, Ethoglucid/therapeutic use, Female, Humans, Male, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local/epidemiology, Neoplasm Staging, Survival Rate, Time Factors, Urinary Bladder Neoplasms/drug therapy, Urinary Bladder Neoplasms/mortality

Relation: The Journal of Urology; https://iris.unil.ch/handle/iris/127283; serval:BIB_2989; A1997XL14300015; 9224307

Availability: https://iris.unil.ch/handle/iris/127283
https://doi.org/10.1016/S0022-5347(01)64484-7

Long-term results of a prospective randomized trial assessing the impact of re-adaptation of the dorsolateral peritoneal layer after extended pelvic lymph node dissection and cystectomy.

Authors: Vartolomei, M.D. Kiss, B. Vidal, A. et al.

Subject Terms: Adult, Aged, 80 and over, Cystectomy/methods, Cystectomy/mortality, Disease-Free Survival, Female, Gastrointestinal Diseases/etiology, Gastrointestinal Diseases/mortality, Humans, Lymph Node Excision/methods, Lymph Node Excision/mortality, Male, Middle Aged, Pelvis, Peritoneum/surgery, Postoperative Complications/etiology, Postoperative Complications/mortality, Preoperative Care, Prospective Studies, Quality of Life, Single-Blind Method, Surgical Flaps, Surveys and Questionnaires, Treatment Outcome, Urinary Bladder Neoplasms/mortality, Urinary Bladder Neoplasms/surgery, Urinary Diversion/methods, bowel function, cystectomy

Relation: BJU International; https://iris.unil.ch/handle/iris/119197; serval:BIB_15252F140738; 000371955600023

Availability: https://iris.unil.ch/handle/iris/119197
https://doi.org/10.1111/bju.13178